Abstract:BackgroundHigh‐ and low‐risk endometrial cancer (EC) differ in whether lymphadenectomy is performed. Assessment of high‐risk EC is essential for planning surgery appropriately.PurposeTo develop a radiomics nomogram for high‐risk EC prediction preoperatively.Study TypeRetrospective.PopulationIn all, 717 histopathologically confirmed EC patients (mean age, 56 years ± 9) divided into a primary group (394 patients from Center A), validation groups 1 and 2 (146 patients from Center B and 177 patients from Centers C–E).Field Strength/Sequence1.5/3T scanners; T2‐weighted imaging, diffusion‐weighted imaging, apparent diffusion coefficient, and contrast enhancement sequences.AssessmentA radiomics nomogram was generated by combining the selected radiomics features and clinical parameters (metabolic syndrome, cancer antigen 125, age, tumor grade following curettage, and tumor size). The area under the curve (AUC) of the receiver operator characteristic was used to evaluate the predictive performance of the radiomics nomogram for high‐risk EC. The surgical procedure suggested by the nomogram was compared with the actual procedure performed for the patients. Net benefit of the radiomics nomogram was evaluated by a clinical decision curve (CDC), net reclassification index (NRI), and integrated discrimination improvement (IDI).Statistical TestsBinary least absolute shrinkage and selection operator (LASSO) logistic regression, linear regression, and multivariate binary logistic regression were used to select radiomics features and clinical parameters.ResultsThe AUC for prediction of high‐risk EC for the radiomics nomogram in the primary group, validation groups 1 and 2 were 0.896 (95% confidence interval [CI]: 0.866–0.926), 0.877 (95% CI: 0.825–0.930), and 0.919 (95% CI: 0.879–0.960), respectively. The nomogram achieved good net benefit by CDC analysis for high‐risk EC. NRIs were 1.17, 1.28, and 1.51, and IDIs were 0.41, 0.60, and 0.61 in the primary group, validation groups 1 and 2, respectively.Data ConclusionThe radiomics nomogram exhibited good performance in the individual prediction of high‐risk EC, and might be used for surgical management of EC.Level of Evidence4Technical Efficacy Stage2 J. MAGN. RESON. IMAGING 2020;52:1872–1882.

Derivation and validation of a nomogram based on clinical characteristics to diagnose endometriosis associated ovarian cancer preoperatively

A novel diagnostic nomogram based on serological and ultrasound findings for preoperative prediction of malignancy in patients with ovarian masses

Development and validation of radiomics nomogram for metastatic status of epithelial ovarian cancer

Development and validation of a prognostic nomogram model incorporating routine laboratory biomarkers for preoperative patients with endometrial cancer

Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma

Preoperative prediction of lymph node metastasis in endometrial cancer patients via an intratumoral and peritumoral multiparameter MRI radiomics nomogram

Multiparameter MRI-based radiomics analysis for preoperative prediction of type II endometrial cancer

Development and Validation of Predictive Model for Lymph Node Metastasis in Endometrial Cancer: a SEER Analysis

A preoperative nomogram incorporating CT to predict the probability of ovarian clear cell carcinoma

Preoperative Assessment for High‐Risk Endometrial Cancer by Developing an MRI‐ and Clinical‐Based Radiomics Nomogram: A Multicenter Study

Integration of pretreatment tumor markers in a nomogram model for prognostic prediction of FIGO stage I endometrial cancer: A multi‐institutional cohort study

A nomogram model based on clinical markers for predicting malignancy of ovarian tumors

Development and Validation of Nomograms Predicting the Overall and the Cancer-Specific Survival in Endometrial Cancer Patients

An Externally Validated Nomogram for Predicting Lymph Node Metastasis of Presumed Stage I and II Endometrial Cancer

A novel clinical nomogram for predicting cancer-specific survival in patients with non-serous epithelial ovarian cancer: A real-world analysis based on the Surveillance, Epidemiology, and End Results database and external validation in a tertiary center

Development and validation of an ultrasound‐based radiomics nomogram to predict lymph node status in patients with high-grade serous ovarian cancer: a retrospective analysis

A nomogram prediction model for lymph node metastasis in endometrial cancer patients

A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1/G2 endometrioid endometrial cancer.

A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1/G2 endometrioid endometrial cancer

A nomogram to predict platinum-sensitivity and survival outcome in women with advanced epithelial ovarian cancer

Nomogram for predicting lymph node metastasis in patients with ovarian cancer using ultrasonography: a multicenter retrospective study